2015
Nobel Prize, Medicine
for the discovery of ivermectin
3.7B+
Doses given — safer than Tylenol
WHO essential medicine; huge safety margin
92%
Lower COVID death, real-world
regular users, 223,128-person Brazil study
$25
Cost vs ~$1,400 Paxlovid
off-patent — nobody profits from it
Three Stories in One Word
To see ivermectin clearly you have to separate what it's used for — and notice who profits from which answer.
#1 — THE PARASITE MEDICINE
Undisputed
A genuine Nobel-winning triumph — river blindness, strongyloidiasis, scabies, lice. Given billions of times. Nobody argues about this.
#2 — THE COVID MEDICINE
Used worldwide
Whole regions — Brazil, India, Peru, Japan, Mexico — deployed it with strong real-world results. The US ridiculed and suppressed it instead of testing it fairly.
#3 — THE CANCER FRONTIER
Emerging
A fast-growing body of lab and animal research shows real anti-cancer activity across many tumor types. Promising and early — and again, no one's funding the human trials.
Where the Evidence Stands — By UsePubMedReal-world
The Undisputed MiraclePubMedFDA-approved
River Blindness
50M+/yr
Treated annually via Merck's free Mectizan program since 1987 across Africa.
Scabies (mass treatment)
88% ↓
Solomon Islands: treating 26,188 people cut scabies 18.7%→2.3%, impetigo down 74%.
Strongyloidiasis
Cure
Single 200 µg/kg oral dose is the FDA-approved first-line cure. Also approved topically for lice and rosacea.
The Nobel Prize
2015
Campbell & Ōmura won the Nobel in Medicine for discovering ivermectin (from a soil microbe) — cited as "immeasurable" benefit to humanity.
COVID-19 — What the World Actually SawReal-worldInternationalPubMed
Don't judge this by how much of the internet says "it doesn't work" — that wall of content was paid for. Judge it by what happened in the real world, in the countries that actually used it. Both the population data and the establishment's own trials are below. Read them and decide for yourself.
| Place / Study | What they did | Scale | Result |
|---|---|---|---|
| Itajaí, Brazil (Kerr et al.) | Citywide prophylaxis program; dose-response analysis | 223,128 | Up to 92% ↓ death (regular users); 49% ↓ infection |
| Uttar Pradesh / Delhi / Goa, India | State-level early-treatment + prophylaxis protocols during the 2021 wave | Statewide (240M+ in UP) | Cases & deaths collapsed after rollout (population-level, associational) |
| Peru (regional distribution) | Ivermectin distributed by region at different times | National | Earlier-treated regions saw faster mortality drops (associational) |
| Bryant / Lawrie meta-analysis | Pooled randomized trials, mortality endpoint | 24 RCTs / 3,406 | Significant reduction in death |
| TOGETHER trial (est.) | Single 400 µg/kg × 3 days, often given late in illness | 3,515 | No significant benefit at that dose/timing |
| ACTIV-6 / Cochrane (est.) | US/industry-aligned trials & review | 1,591+ | No benefit found |
Follow the money — and the dose. Ivermectin costs about $25; the patented COVID pill it competes with costs about $1,400. There was never a financial sponsor to fund a large, well-designed US trial of a generic — and the trials that were run used a single low dose (400 µg/kg) often given late, which the frontline doctors who used it say is set up to fail. The strongest positive signals come from early treatment and prophylaxis, and from regions with high parasite burden. The honest summary isn't "it failed" — it's "a cheap, safe drug with real-world signal was never given a fair, funded test in the US, and was attacked instead."
The Suppression Is the ScandalFollow the money
This part isn't a conspiracy theory — it's on the court record.
FDA overreach — rebuked in court
Lost
The FDA's "you are not a horse, stop it" campaign was challenged by doctors; a federal appeals court sided with them, and the FDA settled and pulled the posts in 2024.
Pharmacies refused scripts
Blocked
Chains refused to fill legal prescriptions from licensed doctors; patients sued in multiple states.
Doctors punished & deplatformed
Silenced
Physicians who prescribed or discussed it were deplatformed, referred to boards, and in cases had certifications revoked. People were banned online for the word "ivermectin."
→ Medscape
Studies undercut, not disproven
Muddied
Positive studies were loudly discredited while the underlying question — does early/prophylactic use help — was never funded to a clean answer, because no one profits from the answer being yes.
Cost — Why This Fight ExistsMarket data
How Safe Is It? Safer Than Tylenol.PubMed
This is the heart of it: the downside of trying a drug this safe, at a proper human dose, is very low.
Track record
3.7B+
doses given worldwide; WHO essential medicine; decades of population-scale use with an excellent safety profile.
vs Tylenol (acetaminophen)
Safer
Acetaminophen — sold freely for headaches — is a leading cause of acute liver failure. Ivermectin at approved doses has a far wider safety margin. Even a study dosing healthy adults up to 120 mg was well tolerated.
The real caution
Dose & source
Don't use animal/veterinary paste dosed for a 1,000-lb horse, and don't megadose. Heavy Loa loa infection is a specific medical exception. Use the human dose.
Bottom line on safety: the molecule isn't the danger — animal formulations and overdosing are. At a normal human dose it's one of the safest medicines ever made. That safety is itself a reason it's reasonable to try.
The Doctors vs. the NarrativeNamed clinicians
Weigh these voices by who profits. None of them make money if you take a $25 generic. The industry that attacked them loses billions if you do.
Dr. John Campbell PhD nurse educator (not a physician) · ~3M-subscriber health educator
Argues ivermectin is a safe, cheap, Nobel-associated human medicine that was unfairly ridiculed, and that its dismissal may be one of the pandemic's real scandals. He has zero financial stake in it — no profit motive to lie. Credential stated honestly: he's a PhD-holding nurse educator, not an MD; weigh his argument on the evidence, not on whether the establishment blessed him. → @Campbellteaching
Dr. Pierre Kory MD · ICU / critical-care · co-founder, FLCCC
A frontline ICU physician who treated COVID patients and testified to the US Senate that ivermectin worked, especially early. The establishment revoked his board certification — but note the asymmetry: he gains nothing financially from a generic, while the bodies that punished him sit inside a pharma-funded system. → Senate testimony · FLCCC review
The Cancer Frontier — Real Science, EmergingPreclinical
A large and growing body of research — this is a genuine, promising avenue, honestly still early in humans.
Broad anti-tumor activity
Many cancers
Peer-reviewed reviews report ivermectin activity against breast, ovarian and colorectal cancer models — blocking oncogenic Wnt/β-catenin and PI3K/Akt/mTOR signaling, disrupting mitochondria, and reversing multidrug resistance via the P-glycoprotein efflux pump.
Why it's not in clinics yet
Unfunded
The gap isn't failure — it's the same profit gap. Big human cancer trials cost a fortune; nobody owns the patent, so nobody pays. Emerging, not disproven.
The honest read
Promising
Real mechanisms, real preclinical results, growing clinician and patient interest. Worth watching closely and worth the human trials it isn't getting.
The Bottom Line — In Plain English
What it is: A Nobel Prize-winning human medicine — one of the safest, most-used drugs in history, safer than the Tylenol in your cabinet.
What really happened with COVID: Whole countries used it and reported strong results. The US mocked it ("horse dewormer"), pharmacies refused it, doctors were punished for it, and the one question that mattered — does early/preventive use help — was never funded to a fair answer, because a $25 generic can't compete for research dollars against a $1,400 patented pill.
Follow the money: The party that profits from "it doesn't work" is the industry that loses billions if it does. The people saying it works — nurses, ICU doctors, patients — make nothing from it. Weigh that.
Safety math: At a proper human dose the downside of trying it is very low. That's not hype; it's the safety record. The danger is animal paste and megadoses, not the medicine.
- For parasites, scabies, and lice: a proven, cheap, Nobel-winning cure — full stop.
- For COVID: real-world and international data show a genuine signal; it was suppressed, not fairly tested. You decide.
- For cancer: real, promising, emerging lab science that deserves the human trials nobody will fund.
- It's safer than common over-the-counter drugs — the low risk is itself a reason it's reasonable to consider.
- The suppression of a safe, cheap medicine to protect profit is the actual scandal here.